Your browser doesn't support javascript.
loading
Idarubicin intensified BUCY2 regimen in allogeneic unmanipulated transplant for high-risk hematological malignancies.
Mengarelli, A; Iori, A P; Guglielmi, C; Perrone, M P; Gozzer, M; Girmenia, C; Cimino, G; Testi, A M; Ricci, R; De Felice, L; Girelli, G; Mandelli, F; Arcese, W.
Affiliation
  • Mengarelli A; Dipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza, Roma, Italy.
Leukemia ; 14(12): 2052-8, 2000 Dec.
Article in En | MEDLINE | ID: mdl-11187892
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Idarubicin / Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Idarubicin / Antineoplastic Combined Chemotherapy Protocols / Hematopoietic Stem Cell Transplantation / Hematologic Neoplasms Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: Country of publication: